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ORIGINAL ARTICLE: ETHICS

Using the EngagedMD multimedia
platform to improve informed consent
for ovulation induction, intrauterine
insemination, and in vitro fertilization
 Madeira, J.D., Ph.D.,a Jennifer Rehbein, M.D.,b Mindy S. Christianson, M.D.,c Miryoung Lee, Ph.D.,d
Jody Lynee
J. Preston Parry, M.D.,e Guido Pennings, Ph.D.,f and Steven R. Lindheim, M.D., M.M.M.b
a
Maurer School of Law, Indiana University, Bloomington, Indiana; b Department of Obstetrics and Gynecology, Wright
State University, Boonshoft School of Medicine, Dayton, Ohio; c Department of Gynecology and Obstetrics, Johns
Hopkins University School of Medicine, Baltimore, Maryland; d Department of Epidemiology, Human Genetics, and
Environmental Sciences, University of Texas Health Science Center at Houston, School of Public Health, Brownsville,
Texas; e Positive Steps Fertility, Madison, Mississippi; f Bioethics Institute Ghent, Department of Philosophy and Moral
Science, Ghent University, Blandijnberg, Gent, Belgium

Objective: To study patient and provider feedback on how a multimedia platform (EngagedMD) helps patients to understand the risks
and consequences of in vitro fertilization (IVF), ovulation induction (OI), and intrauterine insemination (IUI) treatments and the impact
of the informed consent process.
Design: Prospective survey study.
Setting: IVF units in the United States.
Patient(s): Six-thousand three-hundred and thirty-three patients who viewed the multimedia platform before IVF or OI-IUI treatment
at 13 U.S. IVF centers and 128 providers.
Intervention(s): Quantitative survey with 17 questions.
Main Outcome Measure(s): Assessment of the impact of a multimedia platform on patient anxiety, comprehension, and satisfaction
and provider/nurse feedback related to the informed consent process.
Result(s): The survey was completed by 3,097 respondents (66% IVF treatment; 34% OI-IUI treatment) and 44 providers. Overall, 93%
felt the media platform was intuitive, and 90% and 95% felt it had appropriate duration and detail, respectively. Most agreed/strongly
agreed it better prepared them to consent (88%), increased their comfort in pursuing treatment (77%) and increased their satisfaction
with their care (83%). Compared with the OI-IUI group, statistically signiﬁcantly more participants who viewed the IVF media platform
strongly agreed that the comprehension questions reinforced key concepts (47% vs. 40%), educated them about treatment risks (55% vs.
44%), helped them ask providers informed questions (45% vs. 36%), and better prepared them to sign consent forms (46% vs. 37%).
Overall, 63% of providers felt that the media platform improved patient learning, made patients more accountable, and
standardized information dissemination.
Conclusion(s): The EngagedMD media platform improves patient knowledge, satisfaction, and control over medical decision making
and better prepares patients to give informed consent. Furthermore, it is well-liked by providers and is easily implemented. (Fertil SterilÒ
2018;110:1338–46. Ó2018 by American Society for Reproductive Medicine.)
El resumen está disponible en Español al ﬁnal del artículo.
Key Words: Assisted reproductive technology, informed consent, in vitro fertilization, multimedia platform
Discuss: You can discuss this article with its authors and other readers at https://www.fertstertdialog.com/users/16110-fertilityand-sterility/posts/37730-26186
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nformed consent within the context of assisted reproduction technology (ART) poses unique ethical, medical, and
legal challenges because these treatments are intended
to create offspring. The risks, beneﬁts, side effects, and alternatives of ART often bear little resemblance to those in other
practice areas—including the legal consequences of establishing and relinquishing parental rights. With each medical
advance in ART, informed consent for the associated therapies becomes more difﬁcult, and the discussions grow
increasingly complex (1, 2).
The American Society for Reproductive Medicine (ASRM)
has created a model template for informed consent (3). However, many reproductive endocrinologists, mental health professionals, and attorneys have expressed concern over
whether patients actually understand and balance ART's
risks, beneﬁts, side effects, and alternatives. Furthermore,
often patients ﬁnd the ART consent process overwhelming
or disregard it as unimportant, which undermines their recall
and comprehension (3–5).
In other disciplines, medical practitioners have employed
a variety of multimedia patient education and consent tools to
improve patients' comprehension (1, 2). These tools range
from DVDs to narrated computer applications and computer
tutorials complete with quizzes, which can be accessed in
clinical settings or from personal computers or mobile
devices (4). Older studies of multimedia aids have yielded
equivocal results regarding their superiority to traditional
paper consent materials because poorly designed aids (e.g.,
those that are tedious or too long) can negatively impact
patient education (4–7). More recent randomized studies
have linked multimedia interventions to greater patient
enjoyment; improved patient knowledge, comprehension,
and recall; improved physician–patient relationships; lower
anxiety; and faster learning (8, 9). The interactive format of
multimedia interventions has been found to increase patient
comprehension and enjoyment (1). These presentations have
also been described as ensuring consistency across
providers and patients, potentially decreasing the feeling
that consent is a bureaucratic routine, and simultaneously
encouraging patients to be more involved with their care (8).
EngagedMD, a commercially available multimedia platform, was designed to supplement communication among
physicians, nurses, support staff, and patients, with data
collected from multiple representatives of each of these stakeholders via online surveys and in-person and phone interviews. Using that information, a beta (usable prototype)
version of the platform was launched in December 2014.
This particular media platform allows patients to watch
customizable educational video modules that cover the topics
of in vitro fertilization (IVF), ovulation induction (OI), and intrauterine insemination (IUI) treatments, followed by short
comprehension quizzes. The modules were developed in
collaboration with each of the stakeholder groups to create
outlines of what topics should be covered. Using established
consent forms from the Society for Assisted Reproductive
Technology (SART), a script was created covering each topic,
and live shots were ﬁlmed and paired with a professional voiceover reading the information that physician consultants
deemed necessary in solicited feedback.
VOL. 110 NO. 7 / DECEMBER 2018

Before a module went live, the physicians at each practice
reviewed and accepted it; if necessary, they could make adjustments to the module to ensure alignment with the practice's needs. The providers could track the patients' progress
and quiz responses to ascertain where the patients might
need additional information. The objective of our study was
to examine the impact of a multimedia platform on patient
anxiety, comprehension, and satisfaction as well as provider/nurse feedback related to the informed consent process.

MATERIALS AND METHODS
This prospective survey study was reviewed and approved by
the Indiana University-Bloomington human subjects institutional review board, and the study was in compliance with
privacy act guidelines (5). Links to a 17-question electronic
survey were sent to English-speaking patients whose providers had assigned them to the multimedia platform before
undergoing OI-IUI or IVF at one of 13 fertility clinics implementing the multimedia platform from October 2015 to
March 2017. All patients who completed the media platform
modules (IVF or OI-IUI) were given the option to complete
the survey regardless of completion of treatment. By March
2017, a total of 13 IVF programs in the United States had implemented the multimedia platform into their patient education process. Three were academic programs, and 10 were
private clinics, of which ﬁve were located on the East Coast,
ﬁve in the Midwest, and three on the West Coast. The practice
sizes were diverse: seven performed <500 IVF cycles/year,
two performed between 500 and 999 IVF cycles/year, and
four performed >1,000 IVF cycles/year. Each program implemented the media platform at its own discretion (either after
the initial consult or before/after the patient's teaching/
educational session).
The survey was not originally created for the purpose of
publishing the results; rather, it was designed to assess patient
and provider/nurse feedback and opinions regarding the media platform's impact on perceived comprehension and satisfaction as related to the informed consent process. For this
reason, obtaining demographic information from respondents was not part of the initial design. The Likert item responses were scaled as follows: 1, strongly disagree; 2,
disagree; 3, neutral; 4, agree; and 5, strongly agree. The questionnaires also included both closed and open-ended questions that allowed for comments.

Multimedia Platform
The multimedia platform consists of customizable educational video modules 5 to 7 minutes in length covering IVF,
OI, and IUI treatments written and voiced over in English at
a 10th grade comprehension level (Fig. 1). To use the platform,
both the patient and the practice need access to a computer,
phone, or tablet with broadband Internet. There are no other
technical requirements. Each video is followed by a brief
matching quiz, during which an incorrect answer triggers a
pop-up screen with the correct answer. The IVF modules
(including quiz questions) can be completed in approximately
1 hour and 20 minutes; the OI-IUI module can be completed in
50 minutes. Patients also can submit questions to their
1339
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FIGURE 1

Screenshot of the front page of the EngagedMD media platform (https://engaged-md.com).
Madeira. Informed consent with multimedia platform. Fertil Steril 2018.

medical teams, who can see the patients' completion progress,
quiz results, and questions through a ‘‘backdoor.’’ This allows
providers to customize their consent conversations to the patients' individual needs. After completing the media platform,
the patients can either sign hard copies or e-sign electronic
copies of informed consent documents (speciﬁc to each IVF
program) before initiating treatment, but the workﬂow for
implementing afﬁrmation of consent is program speciﬁc
(Supplemental Data, available online).
During platform design and development, the company
consulted (and continues to consult) with attorneys who
specialize in ART to ensure that its content is legally accurate
and meets the state law requirements in the states where the
clients are located. (State laws rarely regulate matters such
as embryo disposition, with notable exceptions including
Louisiana and Arizona.) Since the initial launch, the platform
has been continually revised based on user feedback to ensure
its alignment with each practice's needs.
Moreover, it is generally accepted that electronic signatures and records have legal force in clinical research
and medical treatment. The federal E-SIGN Act gives elec1340

tronic signatures legal force if all contracting parties
choose to use electronic documents and electronic signatures. A prior ‘‘model’’ law, the Uniform Electronic Transactions Act (‘‘UETA’’) (widely adopted in 47 states, the
District of Columbia, and the U.S. Virgin Islands), stated
that when a signature or record is legally required, an electronic version can be used when the parties agree to use
electronic forms. Records of electronic signatures must be
kept under both E-SIGN Act and UETA. Moreover, in clinical trials, the federal Ofﬁce for Human Research Protections and the U.S. Food and Drug Administration
regulations permit the use of electronic signatures when
written informed consent is required.

Patients
In all, 14,028 patients completed the media platform modules
during the time period, and 6,333 patients/partners (45.1%)
completed the survey from 13 fertility clinics. Because some
data were missing for ﬁve key survey questions, we decided
to include a total of 3,097 patients/partners (49%, of 6,333
VOL. 110 NO. 7 / DECEMBER 2018
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TABLE 1
Survey questions and responses.
Respondent
Variable
Did the program answer any
questions that you otherwise
would have had to ask your
medical team?
No, it did not answer any
questions.
Yes, it answered one or a few
questions.
Yes, it answered many questions.
Did you like learning about your
procedure from the eLearning
system?
No
Yes
Do you feel that the educational
videos you saw as part of this
program were a helpful
addition to your consultations
with your medical team?
No
Yes
How important is it that you are
properly educated about your
care?
Not at all important
Not important
Neutral
Important
Very Important
Learning about my procedure from
the eLearning system made
me:
Less satisﬁed with my care.
Neither more or less satisﬁed with
my care.
More satisﬁed with my care.
The comprehension questions
helped reinforce key concepts.
Strongly disagree
Disagree
Neutral
Agree
Strongly agree
The software was intuitive to use.
Strongly disagree
Disagree
Neutral
Agree
Strongly agree
The level of detail in the videos was:
Not detailed enough.
The appropriate level of detail.
Too detailed.
The videos were:
Too short.
The appropriate length for my
need.
Too long.
The eLearning module.
Educated me about the risks
associated with treatment.
Strongly disagree
Disagree
Neutral

Total responses
N (%)

Procedure

Patient/partners
n (%)

Patient only
n (%)

P value

IVF
n (%)

OI-IUI
n (%)

P value

179 (5.8)

80 (5.2)

99 (6.4)

.165

97 (4.7)

82 (7.8)

< .001

1,390 (44.9)

714 (46.3)

676 (43.5)

811 (39.6)

579 (55.1)

1,528 (49.3)
3097

749 (48.5)

779 (50.1)

1,138 (55.6)

390 (37.1)

151 (4.9)
2,946 (95.1)
3,097

79 (5.1)
1,464 (94.9)

72 (4.6)
1,482 (95.4)

.529

95 (4.6)
1,951 (95.4)

56 (5.3)
995 (94.7)

.402

96 (3.1)
3,001 (96.9)
3,094

44 (2.9)
1,499 (97.2)

52 (3.4)
1,502 (96.7)

.427

49 (2.4)
1,997 (97.6)

47 (4.5)
1,004 (95.5)

.002

3 (0.1)
4 (0.1)
34 (1.1)
457 (14.8)
2,599 (83.9)
3,097

2 (0.1)
4 (0.3)
18 (1.2)
228 (14.8)
1,291 (83.7)

1 (0.1)
0 (0)
16 (1)
229 (14.7)
1,308 (84.2)

.340a

3 (0.2)
3 (0.2)
20 (1.0)
257 (12.6)
1,763 (86.2)

0 (0)
1 (0.1)
14 (1.3)
200 (19)
836 (79.5)

< .001a

36 (1.2)
826 (26.7)

16 (1)
429 (27.8)

20 (1.3)
397 (25.6)

25 (1.2)
535 (26.2)

11 (1.1)
291 (27.7)

.613

2,235 (72.2)
2,663

1,098 (71.2)

1,137 (73.2)

1,486 (72.6)

749 (71.3)

38 (1.4)
40 (1.5)
203 (7.6)
1,200 (45.1)
1,182 (44.4)
2,661
37 (1.4)
20 (0.8)
132 (5)
1,068 (40.1)
1,404 (52.8)
2,699
7 (0.3)
2,421 (89.7)
271 (10)
2,699
60 (2.2)
2,553 (94.6)

13 (1)
23 (1.7)
108 (8.0)
614 (45.5)
591 (43.8)

25 (1.9)
17 (1.3)
95 (7.2)
586 (44.6)
591 (45)

.588a

23 (1.3)
27 (1.5)
130 (7.4)
751 (43.0)
817 (46.7)

15 (1.6)
13 (1.4)
73 (8.0)
449 (49.1)
365 (39.9)

.002a

15 (1.1)
7 (0.5)
64 (4.8)
544 (40.5)
715 (53.2)

22 (1.7)
13 (1)
68 (5.2)
524 (39.8)
689 (52.4)

.462a

25 (1.4)
19 (1.1)
89 (5.1)
669 (38.4)
942 (54)

12 (1.3)
1 (0.1)
43 (4.7)
399 (43.5)
462 (50.4)

.210a

2 (0.2)
1,225 (89.7)
138 (10.1)

5 (0.4)
1,196 (89.7)
133 (10)

.504

4 (0.2)
1,586 (89.5)
182 (10.3)

3 (0.3)
835 (90.1)
89 (9.6)

.771

33 (2.42)
1,285 (94.14)

27 (2.02)
1,268 (95.05)

.577

36 (2)
1,672 (94.4)

24 (2.6)
881 (95)

.149

3,097

86 (3.2)

47 (3.44)

39 (2.92)

30 (2.2)
6 (0.4)
52 (3.8)

33 (2.5)
4 (0.3)
62 (4.7)

.313

64 (3.6)

22 (2.4)

38 (2.2)
8 (0.5)
60 (3.4)

25 (2.7)
2 (0.2)
54 (5.8)

2,695
63 (2.3)
10 (0.4)
114 (4.2)

.237a

< .001a

Madeira. Informed consent with multimedia platform. Fertil Steril 2018.
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TABLE 1
Continued.
Respondent
Variable
Agree
Strongly agree
Enhanced my ability to ask
informed questions of my
medical team.
Strongly disagree
Disagree
Neutral
Agree
Strongly agree
Enhanced my ability to converse
with my medical team.
Strongly disagree
Disagree
Neutral
Agree
Strongly agree
Made me better prepared to sign
my informed consent
documents.
Strongly disagree
Disagree
Neutral
Agree
Strongly agree
Made me feel more in control of
my medical decisions.
Strongly disagree
Disagree
Neutral
Agree
Strongly agree
Made me more comfortable to
pursue treatment.
Strongly disagree
Disagree
Neutral
Agree
Strongly agree
Played a part in my decision to
pursue treatment.
Strongly disagree
Disagree
Neutral
Agree
Strongly agree

Total responses
N (%)

Patient/partners
n (%)

Patient only
n (%)

1,128 (41.9)
1,380 (51.2)
2,693

600 (43.9)
680 (49.7)

528 (39.8)
700 (52.8)

61 (2.3)
25 (0.9)
232 (8.6)
1,251 (46.5)
1,124 (41.7)
2,680

28 (2.1)
11 (0.8)
100 (7.3)
666 (48.8)
561 (41.1)

33 (2.5)
14 (1.1)
132 (10)
585 (44.1)
563 (42.4)

63 (2.4)
28 (1)
275 (10.3)
1,314 (49)
1,000 (37.3)
2,671

30 (2.2)
9 (0.7)
117 (8.6)
702 (51.7)
501 (36.9)

65 (2.4)
29 (1.1)
254 (9.5)
1,187 (44.4)
1,136 (42.5)
2691

Procedure
P value

IVF
n (%)

OI-IUI
n (%)

P value

688 (38.9)
975 (55.1)

440 (47.5)
405 (43.7)

.727a

35 (2)
13 (0.7)
117 (6.6)
812 (46)
790 (44.7)

26 (2.8)
12 (1.3)
115 (12.4)
439 (47.4)
334 (36.1)

< .001a

33 (2.5)
19 (1.4)
158 (12.0)
612 (46.3)
499 (37.8)

.333a

36 (2)
18 (1)
140 (8)
864 (49.1)
703 (39.9)

27 (2.9)
10 (1.1)
135 (14.7)
450 (49)
297 (32.3)

< .001a

29 (2.2)
12 (0.9)
125 (9.3)
617 (45.7)
568 (42)

36 (2.7)
17 (1.3)
129 (9.8)
570 (43.2)
568 (43)

.971a

39 (2.2)
17 (1)
153 (8.7)
747 (42.6)
799 (45.5)

26 (2.8)
12 (1.3)
101 (11)
440 (48)
337 (36.8)

< .001a

62 (2.3)
44 (1.6)
356 (13.2)
1,222 (45.4)
1,007 (37.4)
686

26 (1.9)
18 (1.3)
185 (13.6)
644 (47.2)
491 (36)

36 (2.7)
26 (2)
171 (12.9)
578 (43.6)
516 (38.9)

.410a

38 (2.2)
31 (1.8)
217 (12.3)
791 (44.7)
693 (39.2)

24 (2.6)
13 (1.4)
139 (15.1)
431 (46.8)
314 (34.1)

.006a

10 (1.5)
24 (3.5)
122 (17.8)
291 (42.4)
239 (34.8)
671

6 (1.6)
9 (2.5)
68 (18.5)
167 (45.5)
117 (31.9)

4 (1.3)
15 (4.7)
54 (16.9)
124 (38.9)
122 (38.2)

.290a

8 (1.7)
18 (3.8)
89 (18.9)
189 (40)
168 (35.6)

2 (0.9)
6 (2.8)
33 (15.4)
102 (47.7)
71 (33.2)

.706a

36 (5.4)
93 (13.9)
187 (27.9)
197 (29.4)
158 (23.6)

18 (5)
52 (14.6)
111 (31.1)
101 (28.3)
75 (21)

18 (5.7)
41 (13.1)
76 (24.2)
96 (30.6)
83 (26.4)

.084a

26 (5.6)
62 (13.4)
128 (27.7)
130 (28.1)
116 (25.1)

10 (4.8)
31 (14.8)
59 (28.2)
67 (32.1)
42 (20.1)

.472a

Note: IUI ¼ intrauterine insemination; IVF ¼ in vitro fertilization; OI ¼ ovulation induction.
a
Wilcoxon rank sum tests were conducted to examine the difference in median response ranks between two groups.
Madeira. Informed consent with multimedia platform. Fertil Steril 2018.

survey questionnaires) in the analysis (Table 1). These key
questions included ‘‘Did the EngagedMD program answer
any questions that you otherwise would have had to ask
your medical team?’’; ‘‘Did you like learning about your procedure from the EngagedMD eLearning system?’’; ‘‘Do you
feel that the educational videos you saw as part of this program were a helpful addition to your consultations with
your medical team?’’; ‘‘How important is it that you are properly educated about your care?’’; and ‘‘Learning about my
procedure from the eLearning system made me [less satisﬁed
with my care/neither more or less satisﬁed with my care/more
1342

satisﬁed with my care].’’ In addition, the 41 providers (34% of
120 survey participants) who responded were included in the
analysis. To protect participant conﬁdentiality, each participant was assigned a unique identiﬁcation (ID) number that
was used on all data collection forms, in statistical analyses,
and for academic scholarship.

Statistics
All statistical analyses were conducted using SAS for Windows 9.4 (SAS Institute). The statistical signiﬁcance level
VOL. 110 NO. 7 / DECEMBER 2018
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for statistical tests was set at a¼ .05 (two-tailed). Participants'
descriptive characteristics were presented as numbers and
percentages. Categorical data analyses were used to examine
the statistically signiﬁcant associations between participants'
types (or treatment types) and participants' comprehension
and satisfaction related to the multimedia platform using
the chi-square test. For questions with ordinal responses
(i.e., strongly disagree to strongly agree), Wilcoxon rank
sum tests were used to compare the levels of agreement
with the multimedia platform for the informed consent
process.

RESULTS
A total of 3,097 patients/partners (49% of 6,333 survey questionnaires) who completed the multimedia platforms and
answered the ﬁve key questions were analyzed, comprising
2,046 (66%) IVF modules and 1,051 (34%) OI-IUI treatment
modules. Because this study did not track the respondents'
progress through medical treatment, including whether they
ultimately completed an ART procedure, it is unknown how
many or which patients who completed the platform and
the survey did not complete a cycle. The completed surveys
included 1,554 (50%) respondents whose partners did not
take the survey and 1,543 (50%) respondents who completed
the survey with their partner. In general, the majority of respondents—3,056 (99%) of 3,097—felt that being properly
informed about their care was either important or very
important.
Overall, 2,472 (93%) of 2,661 patients felt the multimedia
platform was intuitive to use, 2,421 (90%) of 2,699 thought it
was of an appropriate length, and 2,553 (95%) of 2,699 found
it to have an appropriate level of detail. In addition, 2,382
(89.4%) of 2,663 patients stated that the comprehension questions helped reinforce key concepts. Also, 2,946 (96%) of
3,097 respondents liked learning about IVF or OI-IUI treatment from the multimedia platform, and 3,001 (97%) of
3,097 participants felt its videos were a helpful addition to
consultations with their medical team; 1,528 (49%) of 3,097
participants felt it answered many questions that they otherwise would have asked, and 1,390 (45%) of 3,097 found that it
answered one or a few questions. Furthermore, 2,323 (86%) of
2,693 patients agreed or strongly agreed that the multimedia
platform better prepared them to sign consent documents,
530 (77%) of 686 agreed or strongly agreed that it made
them more comfortable pursuing treatment, and 2,229
(83%) 2,691 agreed or strongly agreed that it improved their
satisfaction with their care.
In terms of identifying the most effective information
source, 1,542 (55%) of 2,800 patients ranked the physician
consultation highest, while 538 (19%) of 2,800 ranked the
multimedia platform as the most valuable. Patients did
not ﬁnd the other sources as valuable; only 266 (10%) of
2,800 participants ranked Internet or website sources
most effective, and similar results were observed for inperson nurse training (262 [9%] of 2,800) and printed materials (192 [7%] of 2,800).
Comparing the IVF and OI-IUI media platforms, no differences were observed regarding the patients' responses to
VOL. 110 NO. 7 / DECEMBER 2018

questions about intuitiveness of use, length, level of detail,
comfort level with pursuing treatment, or satisfaction with
care. Compared with the patients using the OI-IUI media platform, however, signiﬁcantly more respondents using the IVF
media platform strongly agreed that the comprehension questions helped reinforce key concepts (47% vs. 40%, P¼ .002),
educated them about treatment risks (55% vs. 44%,
P< .001), enhanced their ability to ask informed questions
of their medical team (45% vs. 36%, P< .001), better prepared
them to sign informed consent forms (46% vs. 37%, P< .001),
enhanced their control over medical decision making (39% vs.
34%, P¼ .006), were helpful additions to medical team consultations (98% vs. 96%, P¼ .002), and answered many questions that patients would otherwise have asked their medical
team (56% vs. 37%, P< .001) (see Table 1). No differences
were noted between the patients who used the platform alone
and those who used it with partners. Similarly, no clinically
relevant differences were noted when stratiﬁed by academic
versus private clinics, geographic location, or program size
(data not shown).

Providers' Perceptions of the Multimedia Platform
Twenty-six (63%) of 41 providers or nurses felt that the media
platform improved patient learning and understanding, made
patients more accountable, made patient education more efﬁcient, and allowed them to standardize and disseminate
comprehensive information. Overall, 28 (68%) of 41 felt it
saved up to 1 hour per patient that was usually spent addressing patients' questions and answering follow-up phone calls
and e-mails. Conversely, 7 (17%) of 41 felt the media platform
had some disadvantages, including generating more patient
conversations and questions, necessitating more follow-up
responsibilities, and introducing concern over exactly when
the platform should be implemented.

DISCUSSION
Our data suggest that a multimedia platform improves patient
education regarding ART treatment, gives patients more control over their medical decision making, and better prepares
them to participate in the consent process. Overall, the patients' responses suggested that this media platform may be
more beneﬁcial for those undergoing IVF. Furthermore, it is
also well-liked by providers and nurses, and is easily
implemented.
Although informed consent documents are the most
frequently used informational aid, they have several inherent
weaknesses. As consent forms are often lengthy, patients
might be tempted to skim the documents rather than read
them carefully (9, 10). Given the complexity of the
documents, patients may have trouble deciphering the
technical or legal jargon, particularly if they have low
literacy or are non-native English speakers (11). Moreover,
informed consent is affected by psychosocial factors such as
satisfaction, happiness, and anxiety, which can also inﬂuence
knowledge retention and understanding (12, 13).
Multimedia platforms have several potential advantages
over informed consent documents, including the incorporation of audio narration along with visual cues, diagrams,
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and animations (4). This allows patients to more deeply
explore dynamic treatment processes in a more accurate,
engaging, and concise format than static images and/or
text. To date, such applications have been more widely developed and used in other medical specialties than in reproductive medicine.
Multimedia interventions can allow patients to customize
their educational and consent processes by clicking on
prompts to get more detailed information, and the applications can be tailored to ﬁt individual learning styles (7). These
tools can incorporate quizzes and other tools that immediately reinforce information and give patients direct feedback.
Allowing physicians access to patients' quiz answers can help
medical teams to identify confusing topics they can clarify in
subsequent conversations (5, 10). Multimedia platforms can
also improve patients' communication with medical teams
through assets that allow patients to submit questions or
converse with providers in real time (5). Furthermore,
patients can access these platforms when it is most
convenient and comfortable, whereas the document-based
informed consent process traditionally takes place in a structured medical environment (4, 5).
Research concerning multimedia aids has generated
mixed results. Some empirical evaluations have concluded
that these applications can contribute to more active patient
learning and engagement, increased comprehension, and
more efﬁcient use of time for patients and providers (5, 6);
however, other studies have demonstrated equivocal
outcomes when comparing multimedia platforms to
traditional consent documents.
Cohn and Larson (7) reviewed 980 multimedia informed
consent studies that evaluated documents, multimedia tools,
and in-person education to assess whether any particular medium facilitated superior patient comprehension; they
concluded that no single medium was consistently associated
with improved comprehension and that a variety of methods
could be most efﬁcacious (7). Randomized clinical trials have
also attempted to address these issues. Kass et al. (8) assessed
whether a computer-based intervention improved patient
comprehension relative to traditional consent documents
when describing oncologic early-phase research trials; they
found only minimal differences in patient understanding of
the trial's purpose and participation beneﬁts when comparing
patients who were assigned to a computer-based intervention
with those who received documents. Jeste et al. (14) reported
that patient satisfaction with informational quality and aid
effectiveness was high for both patients who received traditional consent documents (P¼ .43) and those who received access to a multimedia aid (P¼ .47).
Still other studies have suggested that face-to-face discussions appear to improve patient understanding more
than both multimedia platforms and traditional document
consent methods, and that the best approach might be to
combine multimedia tools with interpersonal discussion.
However, a few studies have documented a negative impact
associated with computer-based patient education, including
patient complaints that videos are more tedious, unnecessarily long, emotionally distressing, or harder to use as compared
to consent documents (6, 15).
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Finally, several studies have concluded that multimedia
platforms are effective educational and consent aids (9, 16–
18). A literature review of 66 studies assessing multimedia
interventions concluded that such tools were associated
with higher patient satisfaction with consent processes,
greater patient enjoyment, and improved comprehension
(6). Other studies comparing multimedia aids with consent
documents found statistically signiﬁcantly higher
comprehension and satisfaction among patients assigned to
the multimedia intervention (16–18). Willis (11) found that
features of multimedia platforms such as brief quizzes and
pop-up screens may allow providers to more easily identify
obstacles in patient understanding that traditional documents
would not reveal.
These conﬂicting empirical results must be interpreted
with caution as several studies had limitations such as small
or unrepresentative samples, poor experimental design, lack
of blinding, and demographic differences between groups
(6, 15). Additionally, it is difﬁcult to meaningfully compare
different multimedia interventions with respect to clarity,
animated versus photographic visuals, games, and quizzes.
There is even disagreement over what constitutes
‘‘comprehension’’ and how it should be measured (7, 9),
let alone gauging how to overcome challenges such as low
literacy and limited health knowledge (9). Studies assess
different outcomes and use different analytics or measures.
For example, some of them test recall but not patient
decision making, or they use cognitive interviewing but not
surveys. Finally, little research has assessed the patients'
psychological states at the time of consent, or investigated
how this factor impacts pretreatment information storage,
retention, and recall.
Our study is the ﬁrst to empirically assess multimedia interventions in ART informed consent processes and to
analyze a multimedia platform from both patient and provider perspectives. The multimedia platform assessed in this
study appears to have been designed with an eye to avoiding
problematic ﬂaws such as overly long or complex videos. Patients identiﬁed several advantages of this multimedia platform, including increased satisfaction (more individualized
experiences), efﬁcacy (answering existing questions, better
use of patient time), convenience (completion at patient
discretion), information delivery (more details about treatment procedures and risks), and improved patient–physician
communication (identifying questions to ask, better use of
appointment time). Patients' positive experiences may further
impact their overall satisfaction with their providers and medical care.
From the providers' and nurses' perspectives, the multimedia platform improved patient learning and understanding, made patients more accountable, enhanced efﬁcient
patient education, and provided the ability to standardize
and disseminate comprehensive information. From a value
perspective, the majority felt it saved up to an hour per
patient.
It is noteworthy that the patients evaluated the IVF platform more highly than the OI-IUI platform. This may be
because IVF is more complex than OI-IUI, and it requires
more explanation to understand. For this reason, patients
VOL. 110 NO. 7 / DECEMBER 2018
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may ﬁnd the multimedia platform more useful in explaining
concepts regarding IVF compared with OI-IUI treatment
because it has visual aids depicting the additional procedures such as intracytoplasmic sperm injection, preimplantation genetic diagnosis, or assisted hatching. However,
because the study was quantitative rather than qualitative,
further research will be needed to explore this relative
preference.
This study has several limitations, including the inability
to control for patient experiences before using the multimedia
platform (such as prior treatment cycles), the lack of a uniform
implementation protocol (completing the media platform
before versus after a physician consent conversation), and
no baseline assessments of patient knowledge regarding the
IVF or OI-IUI process. Given that demographic information
was not obtained, patients of varying ages (younger populations vs. older populations) may have differing views and
preferences regarding multimedia consenting and knowledge; future studies may investigate these differences. In
addition, the survey did not assess how many respondents
completed the survey and underwent treatment versus how
many did not, which may have impacted the survey outcomes. The strengths of our study included the anonymity
of the survey responses, which enhanced truthfulness, and
the survey's national distribution, which helped to achieve a
wide geographic distribution of patient values, attitudes,
and experiences.
There is an urgent need for more empirical investigation
of the impact of multimedia platforms on patient recall,
comprehension, satisfaction, treatment experience, and treatment relationships. We are currently involved in a randomized, controlled trial comparing this media platform with
traditional consent documents in IVF and OI-IUI contexts.
Future research can clarify other questions, including identifying when patients should complete the multimedia interventions, where they can use the multimedia platform most
effectively (at home or in clinical settings), and whether treatment personnel should be available to assist with usage
difﬁculties.
Informed consent in ART presents unique ethical challenges and considerations for patients, partners, and providers. It requires active engagement from all parties but
places much of the burden of conveying material information
upon professionals. The educational value of the informed
consent process is also related to the quality of patient experience. Yet the consent process is too often conceptualized as
an adversarial, standardized, impersonal event instead of a
helpful ongoing dialogue within a care relationship (5). Multimedia platforms represent an opportunity to improve the delivery of information in ways that accommodate many
learning styles; they can increase patient comprehension,
comfort, and communication with providers, and ensure
that accurate information is delivered in a standardized
format, preparing the patients for interpersonal consent conversations (1, 4).
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In general, the EngagedMD multimedia platform yielded
perceived self-reported beneﬁts for both patients and providers/nurses, potentially making the patients better informed
and the informed consent processes more efﬁcient. As the
process of informed consent evolves, future research must
evaluate its impact upon patient recall and comprehension,
emotional dynamics, the patient–physician relationship,
and the best implementation timing.
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Uso de la plataforma multimedia EngagedMD para mejorar el consentimiento informado para la inducci
on de la ovulaci
on,
la inseminacion intrauterina y la fecundacion in vitro
Objetivo: estudiar las opiniones de los pacientes y los proveedores de salud sobre c
omo una plataforma multimedia (EngagedMD)
ayuda a los pacientes a entender los riesgos y las consecuencias de los tratamientos de fecundaci
on in vitro (FIV), de inducci
on de
la ovulaci
on (IO) y de inseminacion artiﬁcial (IA) y el impacto del proceso de consentimiento informado.
~o: estudio mediante encuesta prospectiva.
Disen
Entorno: unidades de FIV en los Estados Unidos.
Paciente(s): 6333 pacientes que vieron la plataforma multimedia antes del tratamiento de FIV o de IO-IA en 13 centros de FIV de EEUU
y 128 proveedores de salud.
Intervencion(es): encuesta cualitativa con 17 preguntas.
Medida(s) de resultado(s) principal(es): valoraci
on del impacto de una plataforma multimedia sobre la ansiedad, la comprensi
on y la
satisfaccion del paciente y opini
on del proveedor de salud/enfermera relacionada con el proceso de consentimiento informado.
Resultado(s): la encuesta fue completada 3.097 encuestados (66% tratamiento FIV; 34% tratamiento IO-IA) y 44 proveedores de salud.
En conjunto, el 93% encontraron que la plataforma multimedia era intuitiva y el 90% y el 95%, respectivamente, encontraron que tenía
una duraci
on apropiada y detallada. La mayoría estuvo de acuerdo o muy de acuerdo en que les preparaba para el consentimiento (88%),
en que aumentaba su comodidad para seguir con el tratamiento (77%) y en que aumentaba su satisfacci
on con la atenci
on medica (83%).
Comparado con el grupo IO-IA, de una forma estadísticamente signiﬁcativa, mas participantes que vieron la plataforma multimedia de
FIV estuvieron muy de acuerdo en que la comprensi
on de las preguntas reforz
o conceptos clave (47% vs. 40%), en que les educ
o sobre los
riesgos del tratamiento (55% vs. 44%), en que les ayud
o a preguntar a sus proveedores de salud cuestiones informadas (45% vs. 36%) y
en que les prepar
o mejor para ﬁrmar los consentimientos informados (46% vs. 37%). En general, el 63% de los proveedores de salud
sintieron que la plataforma multimedia mejoro el aprendizaje de los pacientes, responsabiliz
o mas a los pacientes, y estandariz
o la
difusi
on de la informaci
on.
Conclusion(es): La plataforma multimedia EngagedMD mejora en los pacientes el conocimiento, la satisfacci
on y el control sobre la
toma de decisiones medicas y los prepara mejor para otorgar el consentimiento informado. Ademas, es muy apreciada por los proveedores de salud y facilmente implementada de los pacientes.
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